Skip to main content
Top
Published in: Critical Care 1/2004

Open Access 01-02-2003 | Research

Procalcitonin as a marker of bacterial infection in the emergency department: an observational study

Published in: Critical Care | Issue 1/2004

Login to get access

Abstract

Introduction

Procalcitonin (PCT) has been proposed as a marker of infection in critically ill patients; its level is related to the severity of infection. We evaluated the value of PCT as a marker of bacterial infection for emergency department patients.

Methods

This prospective observational study consecutively enrolled 120 adult atraumatic patients admitted through the emergency department of a 3000-bed tertiary university hospital in May 2001. Fifty-eight patients were infected and 49 patients were not infected. The white blood cell counts, the serum C-reactive protein (CRP) level (mg/l), and the PCT level (ng/ml) were compared between the infected and noninfected groups of patients.

Results

A white blood cell count >12,000/mm3 or <4000/mm3 was present in 36.2% of the infected patients and in 18.4% of the noninfected patients. The best cut-off serum levels for PCT and CRP, identified using the Youden's Index, were 0.6 ng/ml and 60 mg/l, respectively. Compared with CRP, PCT had a comparable sensitivity (69.5% versus 67.2%), a lower specificity (64.6% versus 93.9%), and a lower area under the receiver operating characteristic curve (0.689 versus 0.879). PCT levels, but not CRP levels, were significantly higher in bacteremic and septic shock patients. Multivariate logistic regression identified that a PCT level ≥ 2.6 ng/ml was independently associated with the development of septic shock (odds ratio, 38.3; 95% confidence interval, 5.6–263.5; P < 0.001).

Conclusions

PCT is not a better marker of bacterial infection than CRP for adult emergency department patients, but it is a useful marker of the severity of infection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20: 864-874.CrossRef Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20: 864-874.CrossRef
2.
go back to reference Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29: 1303-1310. 10.1097/00003246-200107000-00002PubMedCrossRef Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29: 1303-1310. 10.1097/00003246-200107000-00002PubMedCrossRef
3.
go back to reference Kollef MH, Sherman G, Ward S, Fraser VJ: Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999, 115: 462-474. 10.1378/chest.115.2.462PubMedCrossRef Kollef MH, Sherman G, Ward S, Fraser VJ: Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999, 115: 462-474. 10.1378/chest.115.2.462PubMedCrossRef
5.
go back to reference Moscovitz H, Shofer F, Mignott H, Behrman A, Kilpatrick L: Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Crit Care Med 1994, 22: 1102-1107.PubMedCrossRef Moscovitz H, Shofer F, Mignott H, Behrman A, Kilpatrick L: Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Crit Care Med 1994, 22: 1102-1107.PubMedCrossRef
6.
go back to reference Terregino CA, Lopez BL, Karras DJ, Killian AJ, Arnold GK: Endogenous mediators in emergency department patients with presumed sepsis: are levels associated with progression to severe sepsis and death? Ann Emerg Med 2000, 35: 26-34.PubMedCrossRef Terregino CA, Lopez BL, Karras DJ, Killian AJ, Arnold GK: Endogenous mediators in emergency department patients with presumed sepsis: are levels associated with progression to severe sepsis and death? Ann Emerg Med 2000, 35: 26-34.PubMedCrossRef
7.
go back to reference Matson A, Soni N, Sheldon J: C-reactive protein as a diagnostic test of sepsis in the critically ill. Anaesth Intensive Care 1991, 19: 182-186.PubMed Matson A, Soni N, Sheldon J: C-reactive protein as a diagnostic test of sepsis in the critically ill. Anaesth Intensive Care 1991, 19: 182-186.PubMed
8.
go back to reference Povoa P, Almeida E, Moreira P, Fernades A, Mealha R, Aragao A, Sabino H: C-reactive protein as an indicator of sepsis. Intensive Care Med 1998, 24: 1052-1056. 10.1007/s001340050715PubMedCrossRef Povoa P, Almeida E, Moreira P, Fernades A, Mealha R, Aragao A, Sabino H: C-reactive protein as an indicator of sepsis. Intensive Care Med 1998, 24: 1052-1056. 10.1007/s001340050715PubMedCrossRef
9.
go back to reference Carlet J: Rapid diagnostic methods in the detection of sepsis. Infect Dis Clin North Am 1999, 13: 483-494.PubMedCrossRef Carlet J: Rapid diagnostic methods in the detection of sepsis. Infect Dis Clin North Am 1999, 13: 483-494.PubMedCrossRef
10.
go back to reference Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent JL: Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999, 27: 498-504. 10.1097/00003246-199903000-00024PubMedCrossRef Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent JL: Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999, 27: 498-504. 10.1097/00003246-199903000-00024PubMedCrossRef
11.
go back to reference Muller B, Becker KL, Schachinger H, Rickenbacher PR, Huber PR, Zimmerli W, Ritz R: Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000, 28: 977-983. 10.1097/00003246-200004000-00011PubMedCrossRef Muller B, Becker KL, Schachinger H, Rickenbacher PR, Huber PR, Zimmerli W, Ritz R: Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000, 28: 977-983. 10.1097/00003246-200004000-00011PubMedCrossRef
12.
go back to reference Le Moullec JM, Jullienne A, Chenais J, Lasmoles F, Guliana JM, Milhaud G, Moukhtar MS: The complete sequence of human preprocalcitonin. FEBS 1984, 167: 93-97. 10.1016/0014-5793(84)80839-XCrossRef Le Moullec JM, Jullienne A, Chenais J, Lasmoles F, Guliana JM, Milhaud G, Moukhtar MS: The complete sequence of human preprocalcitonin. FEBS 1984, 167: 93-97. 10.1016/0014-5793(84)80839-XCrossRef
13.
go back to reference De Werra I, Jaccard C, Corradin SB, Chiolero R, Yersin B, Gallati H, Assicot M, Bohuon C, Baumgartner JD, Glauser MP, Heumann D: Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 1997, 25: 607-613. 10.1097/00003246-199704000-00009PubMedCrossRef De Werra I, Jaccard C, Corradin SB, Chiolero R, Yersin B, Gallati H, Assicot M, Bohuon C, Baumgartner JD, Glauser MP, Heumann D: Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 1997, 25: 607-613. 10.1097/00003246-199704000-00009PubMedCrossRef
14.
go back to reference Anonymous: The problem of sepsis. An expert report of the European Society of Intensive Care Medicine. Intensive Care Med 1994, 20: 300-304.CrossRef Anonymous: The problem of sepsis. An expert report of the European Society of Intensive Care Medicine. Intensive Care Med 1994, 20: 300-304.CrossRef
15.
go back to reference Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985, 3: 818-829.CrossRef Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985, 3: 818-829.CrossRef
17.
go back to reference Beck JR, Shultz EK: The use of receiver operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med 1986, 110: 13-20.PubMed Beck JR, Shultz EK: The use of receiver operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med 1986, 110: 13-20.PubMed
18.
go back to reference Walker SH, Duncan DB: Estimation of the probability of an event as a function of several independent variables. Biometrika 1967, 55: 167-179.CrossRef Walker SH, Duncan DB: Estimation of the probability of an event as a function of several independent variables. Biometrika 1967, 55: 167-179.CrossRef
19.
go back to reference Pepys MB, Baltz ML: Acute phase proteins with special reference to C-reactive protein and related proteins (pentraxins) and serum amyloid A protein. Adv Immunol 1983, 34: 141-212.PubMedCrossRef Pepys MB, Baltz ML: Acute phase proteins with special reference to C-reactive protein and related proteins (pentraxins) and serum amyloid A protein. Adv Immunol 1983, 34: 141-212.PubMedCrossRef
20.
go back to reference Vigushin DM, Pepys MB, Hawkins PN: Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993, 90: 1351-1357.CrossRef Vigushin DM, Pepys MB, Hawkins PN: Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993, 90: 1351-1357.CrossRef
21.
go back to reference Ballou SP, Kushner I: C-reactive protein and the acute phase response. Adv Int Med 1992, 37: 313-316. Ballou SP, Kushner I: C-reactive protein and the acute phase response. Adv Int Med 1992, 37: 313-316.
22.
go back to reference Bota DP, Ferreira FL, Bross A, Melot C, Vincent JL: Sepsis criteria in critically ill patients [abstract]. Crit Care Med 1999, 27: A142. 10.1097/00003246-199912001-00401CrossRef Bota DP, Ferreira FL, Bross A, Melot C, Vincent JL: Sepsis criteria in critically ill patients [abstract]. Crit Care Med 1999, 27: A142. 10.1097/00003246-199912001-00401CrossRef
23.
go back to reference Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C: Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994, 79: 1605-1608. 10.1210/jc.79.6.1605PubMed Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C: Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994, 79: 1605-1608. 10.1210/jc.79.6.1605PubMed
24.
go back to reference Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993, 27: 515-518. 10.1016/0140-6736(93)90277-NCrossRef Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993, 27: 515-518. 10.1016/0140-6736(93)90277-NCrossRef
25.
go back to reference Eberhard OK, Haubitz M, Brunkhorst FM, Kliem V, Koch KM, Brunkhorst R: Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antinutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997, 40: 1250-1256.PubMedCrossRef Eberhard OK, Haubitz M, Brunkhorst FM, Kliem V, Koch KM, Brunkhorst R: Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antinutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997, 40: 1250-1256.PubMedCrossRef
26.
go back to reference Fleischhack G, Kambeck I, Cipic D, Hasan C, Bode U: Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II. Br J Haematol 2000, 111: 1093-1102. 10.1046/j.1365-2141.2000.02458.xPubMedCrossRef Fleischhack G, Kambeck I, Cipic D, Hasan C, Bode U: Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II. Br J Haematol 2000, 111: 1093-1102. 10.1046/j.1365-2141.2000.02458.xPubMedCrossRef
27.
go back to reference Al-Nawas B, Shah PM: Procalcitonin in patients with and without immunosuppression and sepsis. Infect 1996, 24: 434-436.CrossRef Al-Nawas B, Shah PM: Procalcitonin in patients with and without immunosuppression and sepsis. Infect 1996, 24: 434-436.CrossRef
28.
go back to reference Snider RH Jr, Nylen ES, Becker KL: Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. J Investig Med 1997, 45: 552-560.PubMed Snider RH Jr, Nylen ES, Becker KL: Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. J Investig Med 1997, 45: 552-560.PubMed
29.
go back to reference Nijsten MWN, Olinga P, Hauw The T, De Vries EGE, Koops HS, Groothuis GMM, Limburg PC, Ten Duis HJ, Moshage H, Hoekstra HJ, Bijzet J, Zwaveling JH: Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000, 28: 458-461. 10.1097/00003246-200002000-00028PubMedCrossRef Nijsten MWN, Olinga P, Hauw The T, De Vries EGE, Koops HS, Groothuis GMM, Limburg PC, Ten Duis HJ, Moshage H, Hoekstra HJ, Bijzet J, Zwaveling JH: Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000, 28: 458-461. 10.1097/00003246-200002000-00028PubMedCrossRef
30.
go back to reference Hausfater P, Garric S, Ben Ayed S, Rosenheim M, Bernard M, Riou B: Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study. Clin Infect Dis 2002, 34: 895-901. 10.1086/339198PubMedCrossRef Hausfater P, Garric S, Ben Ayed S, Rosenheim M, Bernard M, Riou B: Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study. Clin Infect Dis 2002, 34: 895-901. 10.1086/339198PubMedCrossRef
31.
go back to reference Guven H, Altintop L, Baydin A, Esen S, Aygun D, Hokelek M, Doganay Z, Bek Y: Diagnostic value of procalcitonin levels as an early indicator of sepsis. Am J Emerg Med 2002, 20: 202-206. 10.1053/ajem.2002.33005PubMedCrossRef Guven H, Altintop L, Baydin A, Esen S, Aygun D, Hokelek M, Doganay Z, Bek Y: Diagnostic value of procalcitonin levels as an early indicator of sepsis. Am J Emerg Med 2002, 20: 202-206. 10.1053/ajem.2002.33005PubMedCrossRef
32.
go back to reference Whang KT, Steinwald PM, White JC, Nylen ES, Snider RH, Simon GL, Goldberg RL, Becker KL: Serum calcitonin precursors in sepsis and systemic inflammation. J Clin Endocrinol Metab 1998, 83: 3296-3301. 10.1210/jc.83.9.3296PubMed Whang KT, Steinwald PM, White JC, Nylen ES, Snider RH, Simon GL, Goldberg RL, Becker KL: Serum calcitonin precursors in sepsis and systemic inflammation. J Clin Endocrinol Metab 1998, 83: 3296-3301. 10.1210/jc.83.9.3296PubMed
Metadata
Title
Procalcitonin as a marker of bacterial infection in the emergency department: an observational study
Publication date
01-02-2003
Published in
Critical Care / Issue 1/2004
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc2396

Other articles of this Issue 1/2004

Critical Care 1/2004 Go to the issue